Clinical Trial: A Study of Apatinib in Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Phase II Study of Apatinib Mesylate Administered as a Daily Oral Treatment in Patients With Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Brief Summary: This is a non-randomized, phase II, open label study of Apatinib Mesylate in patients with Head and neck metastatic adenoid cystic carcinoma (ACC). The primary purpose of this study is to evaluate the efficacy and safety of Apatinib Mesylate in patients with ACC.